{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:44:51Z","timestamp":1783035891904,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Foundation for Support of Science and Technology of Pernambuco State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cca.2025.120177","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:11:06Z","timestamp":1738347066000},"page":"120177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis"],"prefix":"10.1016","volume":"569","author":[{"given":"Eudes Gustavo","family":"Constantino Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-4320","authenticated-orcid":false,"given":"Anderson Rodrigues","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a Tavares","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda","family":"de Oliveira Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelly Cristiny","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Silva","family":"Guimar\u00e3es Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Luzia","family":"Branco Pinto Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacyr Jesus","family":"Barreto de Melo R\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Galdino","family":"da Rocha Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120177_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2025.120177_b0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2025.120177_b0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cca.2025.120177_b0020","first-page":"1567","article-title":"Systemic sclerosis: one year in review 2023","volume":"41","author":"Di Battista","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2025.120177_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biomedicines10010163","article-title":"Systemic sclerosis: from pathophysiology to novel therapeutic approaches","volume":"10","author":"Benfaremo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2025.120177_b0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","article-title":"Systemic sclerosis","volume":"80","author":"Hughes","year":"2019","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.cca.2025.120177_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4569826","article-title":"Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast","volume":"2019","author":"Sierra-Sep\u00falveda","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cca.2025.120177_b0040","article-title":"Pathophysiology of systemic sclerosis","volume":"50","author":"Thoreau","year":"2021","journal-title":"Presse Medicale"},{"key":"10.1016\/j.cca.2025.120177_b0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: Clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cca.2025.120177_b0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.cca.2025.120177_b0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/BOR.0b013e3282e7d8f9","article-title":"Update on autoantibodies in systemic sclerosis","volume":"19","author":"Walker","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2025.120177_b0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cca.2025.120177_b0065","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.5301\/jsrd.5000258","article-title":"Contribution of interleukin-6 to the pathogenesis of systemic sclerosis","volume":"2","author":"Kawaguchi","year":"2017","journal-title":"Journal of Scleroderma and Related Disorders"},{"key":"10.1016\/j.cca.2025.120177_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sji.12694","article-title":"The oncostatin M-stromal cell axis in health and disease","volume":"88","author":"West","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cca.2025.120177_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239732","article-title":"The clinical relevance of OSM in inflammatory diseases: a comprehensive review","volume":"14","author":"Wolf","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120177_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03008207.2018.1500558","article-title":"Oncostatin M and its role in fibrosis","volume":"60","author":"Stawski","year":"2019","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.cca.2025.120177_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.26502\/fccm.92920318","article-title":"Oncostatin M, serpins, and oxidative stress in extracellular matrix remodeling and arteriovenous fistula maturation","volume":"7","author":"DeMarco","year":"2023","journal-title":"Cardiology and Cardiovascular Medicine"},{"key":"10.1016\/j.cca.2025.120177_b0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-020-02266-0","article-title":"The role of the oncostatin M\/OSM receptor \u03b2 axis in activating dermal microvascular endothelial cells in systemic sclerosis","volume":"22","author":"Marden","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2025.120177_b0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/path.2361","article-title":"Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas","volume":"215","author":"Chen","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.cca.2025.120177_b0100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/art.40455","article-title":"Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis","volume":"70","author":"Stifano","year":"2018","journal-title":"Arthritis and Rheumatology"},{"key":"10.1016\/j.cca.2025.120177_b0105","doi-asserted-by":"crossref","unstructured":"A.R. de Almeida, A.T. Dantas, M.C. Pereira, M.J.B. de Melo R\u00eago, R.S. Guimar\u00e3es Gon\u00e7alves, I. da R. Pitta, A.L. Branco Pinto Duarte, D.S. Parra Abdalla, M.G. da Rocha Pitta, Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters, Immunobiology 225 (2020) 151964. https:\/\/doi.org\/10.1016\/j.imbio.2020.151964.","DOI":"10.1016\/j.imbio.2020.151964"},{"issue":"2013","key":"10.1016\/j.cca.2025.120177_b0110","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"classification criteria for systemic sclerosis: An american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2025.120177_b0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2025.120177_b0120","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"1988","key":"10.1016\/j.cca.2025.120177_b0125","first-page":"315","article-title":"revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2025.120177_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109267","article-title":"Global, regional, and national incidence and prevalence of systemic sclerosis","volume":"248","author":"Tian","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2025.120177_b0135","doi-asserted-by":"crossref","first-page":"875","DOI":"10.17219\/acem\/64334","article-title":"Systemic sclerosis sine scleroderma","volume":"26","author":"Kucharz","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.cca.2025.120177_b0140","article-title":"Very early systemic sclerosis, Best Practice & Research","volume":"33","author":"Bellando-Randone","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2025.120177_b0145","doi-asserted-by":"crossref","unstructured":"J.K. Aronson, R.E. Ferner, Biomarkers-A General Review, Current Protocols in Pharmacology 76 (2017) 9.23.1-9.23.17. https:\/\/doi.org\/10.1002\/CPPH.19.","DOI":"10.1002\/cpph.19"},{"key":"10.1016\/j.cca.2025.120177_b0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2125.2005.02435.x","article-title":"Biomarkers and surrogate endpoints","volume":"59","author":"Aronson","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cca.2025.120177_b0155","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.2147\/JIR.S379815","article-title":"Biomarkers in the pathogenesis, diagnosis, and treatment of systemic sclerosis","volume":"16","author":"Muruganandam","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cca.2025.120177_b0160","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/biomedicines10092150","article-title":"Autoantibodies as biomarker and therapeutic target in systemic sclerosis","volume":"10","author":"Gra\u00dfhoff","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2025.120177_b0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0000000000000827","article-title":"Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment","volume":"33","author":"Arron","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2025.120177_b0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0000000000000656","article-title":"Biomarkers in systemic sclerosis","volume":"31","author":"Skaug","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2025.120177_b0175","doi-asserted-by":"crossref","unstructured":"K.K. Pawlik, A. Bohdziewicz, M. Chrab\u0105szcz, A. Stochmal, M. Sikora, R. Alda-Malicka, J. Czuwara, L. Rudnicka, Biomarkers of disease activity in systemic sclerosis, Wiadomosci Lekarskie (Warsaw, Poland\u00a0: 1960) 73 (2020) 2300\u20132305. https:\/\/doi.org\/10.36740\/WLEK202010137.","DOI":"10.36740\/WLek202010137"},{"key":"10.1016\/j.cca.2025.120177_b0180","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: The lessons of the systemic sclerosis autoantibodies","volume":"7","author":"Koenig","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2025.120177_b0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: Anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.cca.2025.120177_b0190","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2010.06.005","article-title":"Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?","volume":"9","author":"Mahler","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2025.120177_b0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1196\/annals.1398.026","article-title":"Antitopoisomerase 1 antibodies in systemic sclerosis: How to improve the detection?","volume":"1109","author":"Tamby","year":"2007","journal-title":"Ann. n. y. Acad. Sci."},{"key":"10.1016\/j.cca.2025.120177_b0200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.clim.2006.12.003","article-title":"Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis","volume":"123","author":"Tamby","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2025.120177_b0205","doi-asserted-by":"crossref","unstructured":"A.T. Dantas, A.R. de Almeida, M.C.P.D. Sampaio, M.F. Cordeiro, P.S.S. de Oliveira, H. de A. Mariz, M.C. Pereira, M.J.B. de M. Rego, I. da R. Pitta, A.L.B.P. Duarte, M.G. da R. Pitta, Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations, Immunology Letters 198 (2018) 12\u201316. https:\/\/doi.org\/10.1016\/j.imlet.2018.03.011.","DOI":"10.1016\/j.imlet.2018.03.011"},{"key":"10.1016\/j.cca.2025.120177_b0210","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.3390\/ijms231911096","article-title":"OSM\/OSMR and interleukin 6 family cytokines in physiological and pathological condition","volume":"23","author":"Lantieri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120177_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1239732","article-title":"The clinical relevance of OSM in inflammatory diseases: a comprehensive review","volume":"14","author":"Wolf","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120177_b0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2397198319865367","article-title":"The JAK\/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib","volume":"5","author":"Wang","year":"2020","journal-title":"Journal of Scleroderma and Related Disorders"},{"key":"10.1016\/j.cca.2025.120177_b0225","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/annrheumdis-2011-200412","article-title":"Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis","volume":"71","author":"Reich","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2025.120177_b0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/keac300","article-title":"Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis","volume":"62","author":"Denton","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2025.120177_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.3246","article-title":"Predicting the long-term effects of therapeutic neutralization of oncostatin M on human hematopoiesis","author":"Thorsted","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2025.120177_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124285","article-title":"Nanoimmunosensor for the electrochemical detection of oncostatin M receptor and monoclonal autoantibodies in systemic sclerosis","volume":"256","author":"Avelino","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.cca.2025.120177_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-02218-8","article-title":"Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension","volume":"22","author":"Di Benedetto","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2025.120177_b0250","first-page":"1","article-title":"S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120177_b0255","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/CCID.S409490","article-title":"Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis","volume":"16","author":"Maciejewska","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:18:44Z","timestamp":1740413924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"alternative-id":["S0009898125000567"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120177","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120177"}}